Galenica AG
GALE
Rank in Stocks
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Share Price
$108.43
Market Cap
$5.40B
Change (1 day)
1.19%
Change (1 year)
-3.89%
Country
CH
Trade Galenica AG (GALE)
Category
Healthcare
Earnings for Galenica AG (GALE)
Earnings in 2026 TTM: 0
According to Galenica AG latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Galenica AG from 2014 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2025 | $280.22M | 17.95% |
| 2024 | $237.57M | 2.48% |
| 2023 | $231.81M | 9.67% |
| 2022 | $211.38M | -1.81% |
| 2021 | $215.28M | -5.25% |
| 2020 | $227.21M | 34.53% |
| 2019 | $168.90M | 49.81% |
| 2018 | $112.74M | -21.46% |
| 2017 | $143.55M | 40.14% |
| 2016 | $102.44M | 2.77% |
| 2015 | $99.67M | 1.17% |
| 2014 | $98.52M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
